Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 16S ribosomal RNA (16S rRNA) is a fundamental structural and functional component of the 30S small ribosomal subunit in prokaryotes, essential for the initiation and accuracy of protein synthesis (UniProt). It plays a vital role in decoding messenger RNA (mRNA) by facilitating the correct pairing of transfer RNA (tRNA) anticodons with mRNA codons at the ribosomal A-site (PubMed, PMID: 11130704). Aminoglycoside antibiotics, including Gentamicin, Amikacin, and G418 (Geneticin), exert their antimicrobial effects by binding specifically to the internal loop of helix 44 within the 16S rRNA (PubChem). This interaction stabilizes a specific conformation of adenine residues that normally signals correct codon-anticodon recognition, thereby forcing the ribosome to accept incorrect tRNAs and leading to the synthesis of mistranslated or truncated proteins (StatPearls). While primarily targeting bacterial ribosomes, certain aminoglycosides like G418 also exhibit activity against eukaryotic 80S ribosomes, making them useful selection agents in laboratory settings but also contributing to potential toxicity in human cells (Sigma-Aldrich). Clinical use of these drugs is often limited by significant safety concerns, including permanent ototoxicity and reversible nephrotoxicity, which require careful therapeutic drug monitoring (NIH, LiverTox). Furthermore, the emergence of resistance through 16S rRNA methyltransferases or aminoglycoside-modifying enzymes remains a major challenge in treating infections (PubMed, PMID: 28438943).
Aminoglycosides bind to the A-site of the 16S ribosomal RNA, inducing conformational changes that lead to mRNA misreading and inhibition of translocation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 16S ribosomal RNA (16S rRNA) (16S rRNA).